These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4185963)

  • 41. [Comparative study of 2 different types of hormone therapy in dysmenorrhea].
    Sereno Coló JA
    Gac Med Mex; 1967 Jul; 97(7):827-35. PubMed ID: 4305128
    [No Abstract]   [Full Text] [Related]  

  • 42. [Single blind method of ENN tablets, a single-blind method].
    Tojo S; Hayashi K; Fukunishi H; Washio M; Masutani S
    Horumon To Rinsho; 1969 Nov; 17(11):943-7. PubMed ID: 4902500
    [No Abstract]   [Full Text] [Related]  

  • 43. [Feedback--regulation mechanisms using a multiple graded mestranol-norethisterone sequential preparation in XO Turner's syndrome].
    Roll H; Breckwoldt M; Amann K
    Arch Gynecol; 1979 Jul; 228(1-4):575-6. PubMed ID: 485482
    [No Abstract]   [Full Text] [Related]  

  • 44. [On the use of a new synthetic estrogen-progestin combination in the treatment of functional gynecologic disorders].
    Fiorino S; Rossi T; Scio A
    Quad Clin Ostet Ginecol; 1966 May; 21(5):282-310. PubMed ID: 5988967
    [No Abstract]   [Full Text] [Related]  

  • 45. [FH 027 in the treatment of dysmenorrhea].
    Kolenc M
    Bord Med; 1970 May; 3(5):1409-10. PubMed ID: 5425890
    [No Abstract]   [Full Text] [Related]  

  • 46. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation].
    Krzywdziński K; Jedrzejewski M; Teter J
    Ginekol Pol; 1969 Jan; 40(1):41-52. PubMed ID: 4181038
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of constitutional hereditary gigantism in girls].
    Lindner J; Dempe A; Bauch K
    Z Arztl Fortbild (Jena); 1981 Mar; 75(6):267-9. PubMed ID: 6169207
    [No Abstract]   [Full Text] [Related]  

  • 48. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy.
    Burnett D; Moore B; Williams JG; Studd JW; Bradwell AR
    Postgrad Med J; 1976; 52 Suppl 6():48-51. PubMed ID: 981119
    [No Abstract]   [Full Text] [Related]  

  • 49. [On the therapeutic use of estrogen-gestagen-combination (AK 103) in gynecologic practice].
    Schmör J
    Wien Klin Wochenschr; 1966 Apr; 78(13):230-2. PubMed ID: 5983528
    [No Abstract]   [Full Text] [Related]  

  • 50. [Efficacy of Non-ovlon in female patients with acne vulgaris].
    Klinger G; Reich P; Hempel E
    Z Arztl Fortbild (Jena); 1970 Dec; 64(3):1202-5. PubMed ID: 4251329
    [No Abstract]   [Full Text] [Related]  

  • 51. Progestin-estrogen combinations in management of acne.
    Kostant GH
    J Med Soc N J; 1965 Nov; 62(11):523-6. PubMed ID: 4220687
    [No Abstract]   [Full Text] [Related]  

  • 52. Behçet's disease. Alleviation of buccal and genital ulceration by an oral contraceptive agent.
    Hewitt AB
    Br J Vener Dis; 1971 Feb; 47(1):52-3. PubMed ID: 4101407
    [No Abstract]   [Full Text] [Related]  

  • 53. Lactation inhibition by norethindrone with mestranol.
    Nickerson CW; Berkman VO
    Rocky Mt Med J; 1967 Jun; 64(6):53-4. PubMed ID: 6044157
    [No Abstract]   [Full Text] [Related]  

  • 54. [The synthetic estrogen-progestagens in therapy of menometrorrhagia of puberty].
    Giambanco V; Di Grigoli D
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1523-33. PubMed ID: 5744195
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapeutic effectiveness of norethindrone-mestranol in dysfunctional uterine bleeding].
    Reyes Ceja L; Zarate A; Guerrero A
    Ginecol Obstet Mex; 1968 Jan; 23(135):103-7. PubMed ID: 5674323
    [No Abstract]   [Full Text] [Related]  

  • 56. Therapeutic utility of norethindrone-mestranol in abnormal uterine bleeding.
    McDonough PG; Greenblatt RB
    Obstet Gynecol; 1966 Apr; 27(4):480-3. PubMed ID: 5907368
    [No Abstract]   [Full Text] [Related]  

  • 57. [Primary inhibition of laction. Comparative study].
    Ruiz Velasco V; Espinosa Vázquez J
    Ginecol Obstet Mex; 1971 May; 29(175):491-503. PubMed ID: 5091934
    [No Abstract]   [Full Text] [Related]  

  • 58. [Indications for the "2-phase-method" in gynecology].
    Kaiser R; Mehring W
    Geburtshilfe Frauenheilkd; 1966 Dec; 26(12):1558-69. PubMed ID: 5973351
    [No Abstract]   [Full Text] [Related]  

  • 59. [The therapeutic use of the sequentially administered oral ovulation inhibitor Ovanon].
    Gimes R; Tóth F
    Dtsch Med J; 1969 Dec; 20(23):718-9. PubMed ID: 5397037
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical study of norethisterone acetate in functional metrorrhagia and in pre- and permenstrual painful syndromes].
    Anglade JP
    Therapie; 1972; 27(5):773-7. PubMed ID: 4675625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.